SHAK STEVEN (Chief Scientific Officer) sold 27.2% of their position (50K shares) of GENOMIC HEALTH INC on the open market
Open‑market sale worth $3.63M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/5/2019ACC: 0001209191-19-044569
Officer· Chief Scientific Officer
Since Jul 2018
-50K
Net shares
Net seller
$3.63M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
50K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−17.63K
Price / share
$72.72
Trade value
$1.28M
% of position
9.6%
8/1/2019
183.79K→166.17K
Common Stock
Indirect
Shares
−7.37K
Price / share
$73.22
Trade value
$539.81K
% of position
4.4%
8/1/2019
166.17K→158.79K
Common Stock
Indirect
Shares
−25K
Price / share
$72.43
Trade value
$1.81M
% of position
15.7%
8/2/2019
158.79K→133.79K
Total
Net shares
−50K
Net value
-$3.63M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/1/2019 | S · Sale | −17.63K | $72.72 | $1.28M | 9.6% | 183.79K | 166.17K |
| Common Stock Indirect | 8/1/2019 | S · Sale | −7.37K | $73.22 | $539.81K | 4.4% | 166.17K | 158.79K |
| Common Stock Indirect | 8/2/2019 | S · Sale | −25K | $72.43 | $1.81M | 15.7% | 158.79K | 133.79K |
| Total | −50K | -$3.63M | ||||||
Derivative Transactions0
No derivative transactions reported